Literature DB >> 12109948

Plasma exchange in patients with toxic epidermal necrolysis.

Gerasimos Bamichas1, Taisir Natse, Fotini Christidou, Maria Stangou, Anna Karagianni, Sotiris Koukourikos, Georgios Chaidemenos, Fotis Chrysomallis, Kostas Sombolos.   

Abstract

We describe our experience with plasma exchange (PE) therapy in 13 patients with drug-induced toxic epidermal necrolysis (TEN), 4 of whom had malignant disorders. Skin lesions covered 17% to 100% of total body surface area and 1 to 4 mucous membranes were involved. None of the patients was hospitalized in a burn unit. The patients underwent from 2 to 5 PE sessions (mean 3.4 +/- 0.2 standard error of mean [SEM], median 3) exchanging 6.6 to 17.6 L of plasma (mean 10.1 +/- 0.7 SEM, median 10). PE sessions were carried out every other day in 8 patients and daily in 5. Three patients died (23%) while the remaining 10 (77%) had a full recovery. Plasmapheresis may be an effective treatment in patients with drug-induced TEN hospitalized outside a burn unit.

Entities:  

Mesh:

Year:  2002        PMID: 12109948     DOI: 10.1046/j.1526-0968.2002.00409.x

Source DB:  PubMed          Journal:  Ther Apher        ISSN: 1091-6660


  12 in total

1.  60-year-old man with rash.

Authors:  Devin E Shahverdian; Constantinos P Anastassiades; Joseph C Charles
Journal:  Mayo Clin Proc       Date:  2009-09       Impact factor: 7.616

2.  Update on the management of antibiotic allergy.

Authors:  Bernard Yu-Hor Thong
Journal:  Allergy Asthma Immunol Res       Date:  2010-03-24       Impact factor: 5.764

3.  Toxic epidermal necrolysis from a cigarette burn.

Authors:  Joshua R Parker; Ross P Berkeley
Journal:  West J Emerg Med       Date:  2010-05

4.  Anesthetic management for emergent Cesarean section in a patient with toxic epidermal necrolysis -A case report-.

Authors:  Jung Hyang Lee; Hyeon Jeong Yang; Byeong-Kuk Yang; Su-Yeon Lee; Chunghyun Park; Dong-Hyun Kim
Journal:  Korean J Anesthesiol       Date:  2010-12-31

5.  Topical clobetasol for the treatment of toxic epidermal necrolysis: study protocol for a randomized controlled trial.

Authors:  Reason Wilken; Chin Shang Li; Victoria R Sharon; Kyoungmi Kim; Falin B Patel; Forum Patel; Emanual Maverakis
Journal:  Trials       Date:  2015-08-22       Impact factor: 2.279

Review 6.  Treatments for Severe Cutaneous Adverse Reactions.

Authors:  Yung-Tsu Cho; Chia-Yu Chu
Journal:  J Immunol Res       Date:  2017-12-27       Impact factor: 4.818

Review 7.  Recent advances in managing and understanding Stevens-Johnson syndrome and toxic epidermal necrolysis.

Authors:  Akito Hasegawa; Riichiro Abe
Journal:  F1000Res       Date:  2020-06-16

Review 8.  Stevens-Johnson syndrome / toxic epidermal necrolysis: an Asia-Pacific perspective.

Authors:  Bernard Yu-Hor Thong
Journal:  Asia Pac Allergy       Date:  2013-10-31

Review 9.  Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Concise Review with a Comprehensive Summary of Therapeutic Interventions Emphasizing Supportive Measures.

Authors:  Jeremy A Schneider; Philip R Cohen
Journal:  Adv Ther       Date:  2017-04-24       Impact factor: 3.845

10.  Toxic epidermal necrolysis in an 8-year-old girl successfully treated with cyclosporin A, intravenous immunoglobulin and plasma exchange.

Authors:  Marzena Zielińska; Łukasz Matusiak; Waldemar Gołębiowski; Katarzyna Swiątek; Iwona Chlebicka; Joanna Maj; Jacek Szepietowski
Journal:  Postepy Dermatol Alergol       Date:  2018-04-24       Impact factor: 1.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.